SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ADVR - Bulls no Bears

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: garden_man who wrote (856)10/24/1997 8:56:00 AM
From: Bernie Bildman  Read Replies (1) of 913
 
Study: Natural molecule may be
promising new HIV drug

October 23, 1997
Web posted at: 7:28 p.m. EDT (2328 GMT)

WASHINGTON (AP) -- Researchers have identified a natural molecule
that prevents HIV from infecting cells, a basic discovery they say
could lead eventually to powerful new types of AIDS drugs or even a
vaccine.

The molecule, discovered by a team led by famed AIDS researcher
Robert Gallo, works against HIV by physically blocking the portal
used by the virus to invade lymphocytes and other types of blood
cells.

Gallo's team at the Institute of Human Virology at the University of
Maryland, Baltimore, earlier identified three similar molecules, all
called chemokines. But the new molecule is much more effective
because it protects all the cell types attacked by HIV, Gallo said.

Flooding the body with these chemokines could create a barrier
between HIV and its target cells, and, thus, prevent the virus from
spreading its deadly infection, Gallo said.

But he emphasized that before chemokines can be tried against HIV
in humans, the molecules must be extensively tested in monkeys
against a related virus called SIV. Such testing could take several
years.

Discovery of the new chemokine comes just as doctors report that
some AIDS virus is developing a resistance to the three-drug
combination that has successfully suppressed HIV in thousands of
patients. That combination of reverse transcriptase and protease
inhibitors works against the virus inside the target cell.

The study by Gallo and his team will be published Friday in the
journal Science.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext